1. Home
  2. Vol 9, No 1 (2023)
  3. Putri

Studi Meta-Analisis: Hubungan antara Defisiensi Vitamin D dan Penyakit Parkinson

DOI: 10.29241/jmk.v9i1.1430

Author

Siti Sarahdeaz Fazzaura Putri(1), Irfannuddin Irfannuddin(2*), Krisna Murti(3), Yudianita Kesuma(4), Noriyuki Koibuchi(5)

(1) Universitas Sriwijaya, Palembang, Indonesia
(2) Universitas Sriwijaya, Palembang, Indonesia
(3) Universitas Sriwijaya, Palembang, Indonesia
(4) Universitas Sriwijaya, Palembang, Indonesia
(5) Gunma University, Japan
(2*) Corresponding Author

Full Text

Full Text: View / Download PDF

Article Metrics

Abstract View : 553 times; PDF Download : 434 times

Abstract

Beberapa penelitian telah dilakukan untuk mengevaluasi kadar 25(OH)D pada pasien penyakit Parkinson. Namun, hasil penelitian ini tidak konsisten. Penelitian ini melakukan meta-analisis terhadap kadar 25(OH)D pada pasien dengan penyakit Parkinson. Database PubMed digunakan untuk melakukan pencarian literatur secara sistematis. Meta-analisis dilakukan dengan menggunakan model efek acak untuk menghitung perkiraan efek gabungan. Tujuh belas artikel dimasukkan dalam penelitian ini. Meta-analisis mengungkapkan bahwa pasien dengan penyakit Parkinson memiliki kadar 25(OH)D yang lebih rendah dibandingkan dengan kontrol. Temuan dari artikel prospektif dan retrospektif sebagian besar konsisten. Besarnya respon nocebo dalam uji coba terkontrol acak yang dirancang paralel pada penyakit Parkinson sangat penting dan harus dipertimbangkan dalam interpretasi hasil keamanan dan dalam desain dan interpretasi uji klinis masa depan.

 


Keywords

25(OH)D, penyakit Parkinson, meta-analysis

References

Barichella, M., Garrì, F., Caronni, S., Bolliri, C., Zocchi, L., Macchione, M. C., … Pezzoli, G. (2022). Vitamin D Status and Parkinson’s Disease. Brain Sciences, 12(6), 790. https://doi.org/10.3390/brainsci12060790

Creed,R. B., & Goldberg, M. S. (2018). New Developments in Genetic rat models of Parkinson’s Disease. Movement Disorders : Official Journal of the Movement Disorder Society, 33(5), 717–729. https://doi.org/10.1002/mds.27296

Evatt, M. L., Delong, M. R., Khazai, N., Rosen, A., Triche, S., & Tangpricha, V. (2008). Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Archives of Neurology, 65(10), 1348–52. https://doi.org/10.1001/archneur.65.10.1348

Evatt, M. L., DeLong, M. R., Khazai, N., Rosen, A., Triche, S., & Tangpricha, V. (2008). Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Archives of Neurology, 65(10), 1348–52. https://doi.org/10.1001/archneur.65.10.1348

Eyles, D. W., Burne, T. H. J., & McGrath, J. J. (2013). Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology, 34(1), 47–64. https://doi.org/https://doi.org/10.1016/j.yfrne.2012.07.001

Foroughi, M., Maghsoudi, Z., Ghiasvand, R., Iraj, B., & Askari, G. (2014). Effect of vitamin D supplementation on C-reactive protein in patients with nonalcoholic fatty liver. International Journal of Preventive Medicine, 5(8), 969–975. Retrieved from https://pubmed.ncbi.nlm.nih.gov/25489444

Kuhn, W., Karp, G., & Müller, T. (2022). No vitamin D deficiency in patients with Parkinson’s Disease. Degenerative Neurological and Neuromuscular Disease, 12, 127–31. https://doi.org/10.2147/DNND.S362511

Luis-Martínez, R., Di Marco, R., Weis, L., Cianci, V., Pistonesi, F., Baba, A., … Antonini, A. (2021). Impact of social and mobility restrictions in Parkinson’s disease during COVID-19 lockdown. BMC Neurology, 21(1), 332. https://doi.org/10.1186/s12883-021-02364-9

Luo, X., Ou, R., Dutta, R., Tian, Y., Xiong, H., & Shang, H. (2018). Association between serum Vitamin D levels and Parkinson’s disease: A systematic review and meta-analysis. Frontiers in Neurology, 9(NOV), 1–10. https://doi.org/10.3389/fneur.2018.00909

Mohseni, H., Hosseini, S. A., Amani, R., Ekrami, A., Ahmadzadeh, A., & Latifi, S. M. (2017). Circulating 25-Hydroxy vitamin D relative to vitamin D receptor polymorphism after vitamin D3 supplementation in breast Cancer Women: A Randomized, Double-Blind Controlled Clinical Trial. Asian Pacific Journal of Cancer Prevention : APJCP, 18(7), 1953–9. https://doi.org/10.22034/APJCP.2017.18.7.1953

Peitl, V., Silić, A., Orlović, I., Vidrih, B., Crnković, D., & Karlović, D. (2020). Vitamin D and Neurotrophin Levels and Their Impact on the Symptoms of Schizophrenia. Neuropsychobiology, 79(3), 179–185. https://doi.org/10.1159/000504577

Petersen, M. S., Bech, S., Christiansen, D. H., Schmedes, A. V., & Halling, J. (2014). The role of vitamin D levels and vitamin D receptor polymorphism on Parkinson’s disease in the Faroe Islands. Neuroscience Letters, 561, 74–79. https://doi.org/https://doi.org/10.1016/j.neulet.2013.12.053

Riwu, S. L., & Wibowo, A. (2021). Penilaian kinerja rumah sakit dengan menggunakan pendekatan balanced scorecard: Systematic review. Jurnal Manajemen Kesehatan Yayasan RS.Dr. Soetomo, 7(2), 267. https://doi.org/10.29241/jmk.v7i2.638

Sepidarkish, M., Farsi, F., Akbari-Fakhrabadi, M., Namazi, N., Almasi-Hashiani, A., Maleki Hagiagha, A., & Heshmati, J. (2019). The effect of vitamin D supplementation on oxidative stress parameters: A systematic review and meta-analysis of clinical trials. Pharmacological Research, 139, 141–52. https://doi.org/https://doi.org/10.1016/j.phrs.2018.11.011

Sleeman, I., Aspray, T., Lawson, R., Coleman, S., Duncan, G., Khoo, T. K., … Yarnall, A. (2017). The role of vitamin D in disease progression in early Parkinson’s disease. Journal of Parkinson’s Disease, 7(4), 669–75. https://doi.org/10.3233/JPD-171122

Tagliaferri, S., Porri, D., De Giuseppe, R., Manuelli, M., Alessio, F., & Cena, H. (2019). The controversial role of vitamin D as an antioxidant: results from randomised controlled trials. Nutrition Research Reviews, 32(1), 99–105. https://doi.org/DOI: 10.1017/S0954422418000197

Van den Bos, F., Speelman, A. D., van Nimwegen, M., van der Schouw, Y. T., Backx, F. J. G., Bloem, B. R., … Verhaar, H. J. J. (2013). Bone mineral density and vitamin D status in Parkinson’s disease patients. Journal of Neurology, 260(3), 754–760. https://doi.org/10.1007/s00415-012-6697-x

Wang, J., Yang, D., Yu, Y., Shao, G., & Wang, Q. (2016). Vitamin D and sunlight exposure in newly-diagnosed Parkinson’s disease. Nutrients, 8(3), 142. https://doi.org/10.3390/nu8030142

Wu, H., Khuram Raza, H., Li, Z., Li, Z., Zu, J., Xu, C., … Cui, G. (2022). Correlation between Serum 25(OH)D and Cognitive Impairment in Parkinson’s Disease. Journal of Clinical Neuroscience, 100, 192–5. https://doi.org/10.1016/j.jocn.2022.04.015

Zhao, Y., Sun, Y., Ji, H.-F., & Shen, L. (2013). Vitamin D levels in Alzheimer’s and Parkinson’s diseases: A meta-analysis. Nutrition, 29(6), 828–32. https://doi.org/https://doi.org/10.1016/j.nut.2012.11.018

Refbacks

  • There are currently no refbacks.




Copyright (c) 2023 Jurnal Manajemen Kesehatan Yayasan RS.Dr. Soetomo

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.